Diabetes Management and ResearchDiabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and LipoproteinsDiabetes and associated disordersCardiovascular Function and Risk Factors
Publications
295
Citations
7,602
Est. group size
—
Recurring co-author estimate
Active years
61
Publishing since 1965
Publication cadence
Publications per year over the last 10 years — averaging 9.2/year recently
Recent publications
- Diabetic distal symmetric polyneuropathy: More than just “tingling in the feet”
Diabetes Obesity and Metabolism · 2025
- In adults with obesity and knee OA, adding weekly semaglutide to diet and activity counseling reduced weight and knee pain at 68 wk
Annals of Internal Medicine · 2025
- Pseudoascites Due to Celiac Disease in a Patient with Type 1 Diabetes
Diabetes Therapy · 2025
- Successful Utilization of the GLP-1 Receptor Agonist Semaglutide in Treating the Manifestations of Recalcitrant Celiac Disease
Archives of Clinical and Biomedical Research · 2025
- Author response for "Diabetic distal symmetric polyneuropathy: More than just “tingling in the feet”"
2025
- Author response for "Diabetic distal symmetric polyneuropathy: More than just “tingling in the feet”"
2025
- No, It Doesn’t Go Without Saying: Energy Justice, Public Investment, and Social Entrepreneurship—A Clean Energy Heuristic
Public Integrity · 2025
- Obesity and abdominal hernia in ambulatory patients, 2018–2023
Hernia · 2024
- The potential for improved outcomes in the prevention and therapy of diabetic kidney disease through ‘stacking’ of drugs from different classes
Diabetes Obesity and Metabolism · 2024
- Diabetic Charcot neuroarthropathy: A threat to both limb and life
Diabetes Obesity and Metabolism · 2024
- All That Glistens Is not Gold: Neuropathy in Diabetic Patients May not Be Exclusively due to Diabetes
Endocrine Practice · 2024
- Exogenous Insulin Antibody Syndrome (EIAS) Presenting in an Elderly, Long-Term Patient with Type 1 Diabetes Mellitus that Resolved with Low-Cost Outpatient Therapy with Mycophenolate Mofetil and Regular Insulin by Pump
Diabetes Therapy · 2024
- Author response for "The potential for improved outcomes in the prevention and therapy of diabetic kidney disease through ‘stacking’ of drugs from different classes"
2024
- Letter to the Editor Regarding “Real Practice Assessment of Persistent Symptoms After Initiation of Levothyroxine”
Endocrine Practice · 2024
- The Role of Teplizumab in Newly Diagnosed Type 1 Diabetes
Endocrine Practice · 2024
Publishes in
- Diabetes Obesity and Metabolism×15
- Diabetes Therapy×10
- Endocrine Practice×4
- Frontiers in Medical Case Reports×4
- Annals of Internal Medicine×2
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 9, 2026.
Claim or correct this profile